Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Bondy, C. A.    Skarulis, M.    Related Articles in PubMed    PubMed Citation    PubMed

NIH CONFERENCE

Clinical Uses of Insulin-like Growth Factor I

Carolyn A. Bondy; Louis E. Underwood; David R. Clemmons; Hans-Peter Guler; Mark A. Bach; and Monica Skarulis

1 April 1994 | Volume 120 Issue 7 | Pages 593-601

Insulin-like growth factor I (IGF-I) has acute insulin-like metabolic effects and long-term anabolic actions. The therapeutic potential of recombinant human IGF-I treatment is being investigated in various growth hormone-resistant and insulin-resistant disorders. Recent studies have shown that IGF-I may substitute for growth hormone in promoting linear growth in children with growth hormone insensitivity. The anabolic, protein-sparing action of IGF-I is being evaluated as a potential therapy for adults with catabolic diseases. Patients with insulin-dependent diabetes mellitus have reduced endogenous IGF-I production, and studies are in progress to determine whether treatment with IGF-I in addition to insulin may improve their metabolic/anabolic status. Insulin-like growth factor I treatment may reduce glucose and triglyceride levels in adults with non-insulin-dependent diabetes mellitus and in some patients with extreme insulin resistance. Further studies are needed to evaluate the efficacy and safety of IGF-I treatment in these and other conditions and to provide a better understanding of this hormone's normal physiologic role(s) and complex relations with growth hormone and insulin.

Author and Article Information

An edited summary of a Combined Clinical Staff Conference held 24 February 1993 at the National Institutes of Health, Bethesda, Maryland.
Authors who wish to cite a section of the conference and specifically indicate its author can use this example for the form of reference:
Underwood LE. Insulin-like growth factor I in growth hormone-resistant short stature, pp 594-596. In: Bondy CA, moderator. Clinical uses of insulin-like growth factor I. Ann Intern Med. 1994; 120:593-601.
Requests for Reprints: Carolyn Bondy, MD, National Institutes of Health, Building 10, Room 10N 262, 9000 Rockville Pike, Bethesda, MD 20892.

This article has been cited by other articles:

				M. G. Jeschke, U. Bolder, D. H. Chung, R. Przkora, U. Mueller, J. C. Thompson, S. E. Wolf, and D. N. Herndon Gut Mucosal Homeostasis and Cellular Mediators after Severe Thermal Trauma and the Effect of Insulin-Like Growth Factor-I in Combination with Insulin-Like Growth Factor Binding Protein-3 Endocrinology, January 1, 2007; 148(1): 354 - 362. [Abstract] [Full Text] [PDF]

				H.-Y. Lee, Y. S. Chang, J.-Y. Han, D. D. Liu, J. J. Lee, R. Lotan, M. R. Spitz, and W. K. Hong Effects of 9-cis-Retinoic Acid on the Insulin-Like Growth Factor Axis in Former Smokers J. Clin. Oncol., July 1, 2005; 23(19): 4439 - 4449. [Abstract] [Full Text] [PDF]

				M. D. Holmes, M. N. Pollak, and S. E. Hankinson Lifestyle Correlates of Plasma Insulin-like Growth Factor I and Insulin-like Growth Factor Binding Protein 3 Concentrations Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 862 - 867. [Abstract] [Full Text] [PDF]

				S. Boonen, C. Rosen, R. Bouillon, A. Sommer, M. McKay, D. Rosen, S. Adams, P. Broos, J. Lenaerts, J. Raus, et al. Musculoskeletal Effects of the Recombinant Human IGF-I/IGF Binding Protein-3 Complex in Osteoporotic Patients with Proximal Femoral Fracture: A Double-Blind, Placebo-Controlled Pilot Study J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1593 - 1599. [Abstract] [Full Text] [PDF]

				M. G. Jeschke, D. N. Herndon, C. Ebener, R. E. Barrow, and K.-W. Jauch Nutritional Intervention High in Vitamins, Protein, Amino Acids, and {omega}3 Fatty Acids Improves Protein Metabolism During the Hypermetabolic State After Thermal Injury Arch Surg, November 1, 2001; 136(11): 1301 - 1306. [Abstract] [Full Text] [PDF]

				K. Sjogren, K. Wallenius, J.-L. Liu, M. Bohlooly-Y, G. Pacini, L. Svensson, J. Tornell, O. G.P. Isaksson, B. Ahren, J.-O. Jansson, et al. Liver-Derived IGF-I is of Importance for Normal Carbohydrate and Lipid Metabolism Diabetes, July 1, 2001; 50(7): 1539 - 1545. [Abstract] [Full Text] [PDF]

				V. De Leo, A. la Marca, G. Morgante, L. Ciotta, L. Mencaglia, A. Cianci, and F. Petraglia Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome Hum. Reprod., November 1, 2000; 15(11): 2302 - 2305. [Abstract] [Full Text] [PDF]

				M. G. Jeschke, R. E. Barrow, H. K. Hawkins, M. T. Chrysopoulo, J. R. Perez-Polo, and D. N. Herndon Effect of Multiple Gene Transfers of Insulinlike Growth Factor I Complementary DNA Gene Constructs in Rats After Thermal Injury Arch Surg, October 1, 1999; 134(10): 1137 - 1141. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				A. Cittadini, Y. Ishiguro, H. Stromer, M. Spindler, A. C. Moses, R. Clark, P. S. Douglas, J. S. Ingwall, and J. P. Morgan Insulin-like Growth Factor-1 but Not Growth Hormone Augments Mammalian Myocardial Contractility by Sensitizing the Myofilament to Ca2+ Through a Wortmannin-Sensitive Pathway : Studies in Rat and Ferret Isolated Muscles Circ. Res., June 13, 1998; 83(1): 50 - 59. [Abstract] [Full Text] [PDF]

				P. S. Hinton, C. A. Peterson, E. M. Dahly, and D. M. Ney IGF-I alters lymphocyte survival and regeneration in thymus and spleen after dexamethasone treatment Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R912 - R920. [Abstract] [Full Text] [PDF]

				M. I. Lewis, T. J. Lorusso, and M. Fournier Anabolic influences of insulin-like growth factor I and/or growth hormone on the diaphragm of young rats J Appl Physiol, June 1, 1997; 82(6): 1972 - 1978. [Abstract] [Full Text] [PDF]

				A. K. Berfield, D. Spicer, and C. K. Abrass Insulin-like Growth Factor I (IGF-I) Induces Unique Effects in the Cytoskeleton of Cultured Rat Glomerular Mesangial Cells J. Histochem. Cytochem., April 1, 1997; 45(4): 583 - 594. [Abstract] [Full Text] [PDF]

				D. Le Roith Insulin-Like Growth Factors N. Engl. J. Med., February 27, 1997; 336(9): 633 - 640. [Full Text] [PDF]

				E. Wolf, P. M. Jehle, M. M. Weber, H. Sauerwein, A. Daxenberger, B. H. Breier, U. Besenfelder, L. Frenyo, and G. Brem Human Insulin-Like Growth Factor I (IGF-I) Produced in the Mammary Glands of Transgenic Rabbits: Yield, Receptor Binding, Mitogenic Activity, and Effects on IGF-Binding Proteins Endocrinology, January 1, 1997; 138(1): 307 - 313. [Abstract] [Full Text] [PDF]

				H. Stromer, A. Cittadini, P. S. Douglas, and J. P. Morgan Exogenously Administered Growth Hormone and Insulin-like Growth Factor-I Alter Intracellular Ca2+ Handling and Enhance Cardiac Performance: In Vitro Evaluation in the Isolated Isovolumic Buffer-Perfused Rat Heart Circ. Res., August 1, 1996; 79(2): 227 - 236. [Abstract] [Full Text]

				A. Cittadini, H. Stromer, S. E. Katz, R. Clark, A. C. Moses, J. P. Morgan, and P. S. Douglas Differential Cardiac Effects of Growth Hormone and Insulin-like Growth Factor1 in the Rat : A Combined In Vivo and In Vitro Evaluation Circulation, February 15, 1996; 93(4): 800 - 809. [Abstract] [Full Text]